Physician profile
Deborah Nelson
NPI 1184680415
$12,664.24
in general payments reported to CMS, 2019-2025
49 companies · $2,735 in 2025
The $2,735 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,432 · 2022: $2,193 · 2023: $4,643 · 2024: $1,660 · 2025: $2,735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,251 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,495 · Travel and Lodging: $247 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,251.34 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,495.00 |
| Travel and Lodging | $247.47 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,719.56 | 2022-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Abbvie INC. | $2,182.93 | 2021-2025 | |
| Lundbeck LLC | $880.75 | 2021-2025 | Vyepti |
| Collegium Pharmaceutical, INC. | $823.79 | 2021-2025 | Xtampza, Belbuca |
| Relievant Medsystems, INC. | $775.03 | 2022-2023 | Intracept |
| Globus Medical, INC. | $506.21 | 2025 | Senza |
| Lilly USA, LLC | $366.26 | 2021-2023 | Reyvow, Emgality |
| Idorsia Pharmaceuticals US INC | $310.42 | 2022-2023 | Quviviq |
| Vertos Medical, INC. | $285.48 | 2023-2024 | Mild Device Kit |
| Averitas Pharma INC. | $267.47 | 2023-2025 | Qutenza |
| Biotronik Nro, INC. | $246.41 | 2024-2025 | Prospera |
| Scilex Pharmaceuticals INC. | $243.12 | 2021-2025 | Ztlido |
| Boston Scientific Corporation | $232.81 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Pfizer INC. | $225.32 | 2021-2025 | |
| Impel Pharmaceuticals INC. | $222.26 | 2023 | Trudhesa |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.